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Abstract 
 
Cardiovascular disease (CVD) claims more lives than any other disease in the 
world. Although numerous biological pathways share the blame, ventricular 
tachyarrhythmia (VT) is estimated to account for ~25% of all CVD deaths. A 
complete understanding of the molecular mechanisms underlying VT is unknown 
but recent studies have linked VT to improper calcium handling in the heart 
(canine). The principle calcium regulator in the muscle cell is the calcium ion 
release channel (aka RyR). Numerous endogenous and exogenous compounds 
can affect the way the RyR regulates calcium. In particular, abnormal levels of 
oxidants (reactive oxygen species) can oxidize critical thiol groups on the RyR 
and modulate its activity. Interestingly, high levels of oxidants are also associated 
with numerous bodily disease states including cancers, muscle fatigue/failure, 
and CVD. 
 
In this thesis, two important dietary antioxidant compounds, the anthocyanidins 
pelargonidin and delphinidin, are evaluated for their effects on regulating the 
transport of calcium through the calcium release channel (RyR1) of the 
sarcoplasmic reticulum of skeletal muscle. Pelargonidin and delphinidin are 
structurally similar with delphinidin only differing from pelargonidin by the addition 
of two hydroxyl groups. Both compounds undergo time dependent structural 
changes in aqueous solutions at physiological pH and a mixture of more than 
 ii 
four structures of each compound can be present in solution simultaneously. 
Pelargonidin and delphinidin show distinct differences in their calcium flux 
regulating effect on the RyR1. Delphinidin stimulates calcium flux and RyR1 
activity whereas pelargonidin can cause both inhibition and stimulation of the 
RyR1. The strength of stimulation and inhibition of calcium transport through the 
RyR by delphinidin and pelargonidin may be attributed to the structural and 
chemical changes in those compounds that occur in solutions near physiological 
pH and the subsequent chemical characteristics of the diverse set of structures 
that are simultaneously present in solution. 
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 1
1  Introduction 
 
Cardio vascular disease (CVD) causes more deaths than any other disease on 
the globe (World Health Organization). Although CVD encompasses numerous 
distinct pathological mechanisms, sudden cardiac death (SCD), the abrupt loss 
of heart function, is estimated to account for approximately 50% of CVD related 
deaths. A majority of the SCD fatalities is attributed to ventricular tachyarrythmias 
(VT) (Huikuri, Castellanos, and Myerburg 2001). In an effort to improve the 
quality of life for non-fatal CVD victims, reduce CVD deaths, and minimize the 
enormous economic costs associated with CVD, extensive epidemiological 
studies and laboratory research continue to be funded and performed in hopes to 
better explain the pathological molecular mechanisms of CVD.  
Figure 1.1 Heart Disease, Anti/Pro Oxidants, and Ca
2+
 handling  
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Non-behavioral risk factors of CVD include increasing age, male gender, and 
heredity related factors (children of people with heart disease and race related 
increased risks). Behavioral risk factors (ones that we can change) account for 
over 90% of the risk of heart failures (HF). These factors include cigarette 
smoking, abnormal blood lipid levels (high cholesterol), hypertension (high blood 
pressure related), diabetes, abdominal obesity, a lack of physical activity, low 
daily fruit and vegetable consumption, alcohol over consumption, and 
psychosocial index. (AHA-Heart and Stroke Update 4/2009 referenced Lancet. 
2004;364:937–952). 
Interestingly, a subsequent epidemiological study found an exception to that rule, 
the people of southern France consume more fat and smoke more cigarettes 
than other countries with a similar incidence of CVD deaths. Additional studies 
revealed that the same population also had a slightly different diet which included 
higher intakes of vegetables, fruits, and wine. The lower incidence of CVD was 
quickly attributed to the constituents of those foods which were abundant in 
flavonoid antioxidant compounds. Since then, research has been conducted on 
almost every conceivable natural antioxidant to be found in those foods. 
Extensive quantitative-structure activity relationship (QSAR) studies have 
characterized those compounds for their antioxidant properties. Naturally, those 
compounds that exhibited the highest level of antioxidant activity in vitro were 
perceived as the best of the best’. These compounds have been studied 
extensively in the literature. If antioxidants are the ‘cure’, then it follows that 
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oxidants may be the cause. Researchers targeted native reactive oxidant species 
(ROS) and studied their effects on the proliferation of CVD biomarkers in vitro. 
The results all seem to imply that ROS cause severe damage to biological 
processes and can be attributed to increased incidence of several CVD 
pathologies. In addition to the ROS connection, recent studies (Lehnart et al. 
2004; Belevych et al. 2007; Belevych et al. 2008; Belevych et al. 2009; Belevych 
and Terentyev 2010) related to ventricular tachyarrythmias, a significant 
contributor to sudden heart failure, have shown a connection between VT and 
increased levels (overload) of calcium (Ca2+) in the heart muscle cell via ‘leaky’ 
calcium release ion channels (ryanodine receptor). The ryanodine receptor (RyR) 
is known to have reactive thiol residues that are extremely sensitive to the 
oxidation by ROS and numerous other compounds. Oxidation of these thiols can 
causes increased channel activity and Ca2+ conductance (J.J. Abramson and G. 
Salama 1988; Jonathan J. Abramson and Guy Salama 1989; J. J. Abramson et 
al. 1988; J. J Abramson, Cronin, and G. Salama 1988). 
There may indeed be a connection between increased oxidative stress in the cell 
(oxidative stress) and abnormal calcium handling by the RyR (calcium overload) 
in cardiac myocytes, and deaths by ventricular tachyarrythmias. Dietary 
antioxidants that play a part in reducing ROS in the cell may indeed have part in 
the decreased incidence of CVD deaths of those populations engaged in higher 
(disease) risk activities. However, numerous studies have shown that antioxidant 
compounds, especially the good ones, can also act as prooxidants. These 
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antioxidant compounds have also been shown to bind to proteins and protective 
enzymes impacting their function (Graziani et al. 1982; Kaldas et al. 2005). The 
intention of the investigation of various dietary antioxidants is to characterize that 
compound for its potential beneficial properties and its potential deleterious 
properties so that fully informed and educated decisions can be made as to 
whether or not their benefits outweigh their risks. Due to the possible prooxidant 
activity of flavonoid antioxidants, it is clear that before recommendations can be 
made regarding their dietary inclusion, any impact that they may have on other 
biological systems must be understood. Given the importance of Ca2+ 
homeostasis in both skeletal and cardiac muscle, the interaction of these 
compounds need to be evaluated with regards to their possible modulation 
effects on the RyR. 
 
1.1 Oxidative Stress and Calcium Homeostasis in Muscle 
Calcium can signal and activate biological processes via dynamic variations in its 
concentration within cells. The concentration of free Ca2+ is generally controlled 
by its transport in and out of the cytoplasm of cells by ion channel proteins 
located in the membrane of the endoplasmic/sarcoplasmic reticulum organelles 
within the cell. This Ca2+ movement alters the cytoplasmic (intra-cellular) Ca2+ 
concentration which in turn impacts Ca2+ binding to various biological substrates. 
An important example of Ca2+ signaling is the binding of Ca2+ to specific muscle 
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cell proteins. This interaction is mandatory for our muscles to contract and it also 
controls how much force is generated during the contraction. Indeed, without 
Ca2+ signaling, our muscles would cease to function and we would die. Improper 
functioning of the Ca2+ regulatory proteins can lead to pathological Ca2+ 
homeostasis conditions that can severely decrease the quality of human life and 
also lead to eventual death. The importance of knowing how Ca2+ levels in 
muscle cells is regulated and knowing what cause changes in that regulation 
cannot be overstated. Studies to determine why muscles malfunction, fatigue, 
and fail have consumed researchers for many decades. Although the normal 
functioning of the muscle is the result of synergistic cooperation from numerous 
proteins that reside in the muscle cell, the main regulatory protein, the one that 
controls the fast Ca2+ transient signals within the cell, is called the ryanodine 
receptor (RyR). The RyR is, simply put, the valve that opens and closes 
controlling the concentration of Ca2+ within the cell. Increased Ca2+levels allow 
for the Ca2+ - protein interactions that allow the contractile process of the muscle 
to occur. The RyR is very sensitive to the environment within the cell. It is 
sensitive to Ca2+ concentrations, the redox environment, binding of other closely 
associated proteins, and numerous other endogenous and exogenous 
compounds. All of these can have an effect on the way the RyR manages the 
Ca2+ level in the cell. This is of utmost importance because too much, or too little, 
Ca2+ can cause the concert of cooperation between the cellular proteins to 
breakdown which may lead to various pathological conditions and even death. It 
 6
has been shown that one of the most important cellular conditions, with regards 
to proper Ca2+ homeostasis regulation by the RyR, is the redox environment 
within the cell (Jonathan J. Abramson and Guy Salama 1989; Jonathan J. 
Abramson and Guy Salama 1988; J. L. Trimm, G. Salama, and J. J. Abramson 
1986). The redox potential in the cell is related to the relative ease in which the 
constituents in the cell environment can reduce (donate electrons or hydrogens 
to) the RyR or oxidize (accept electrons or hydrogens from) the RyR. The RyR is 
a large homotetrameric membrane protein containing approximately 5000 amino 
acids and weighing more than 2.2 megadaltons. The protein contains 
approximately 320-400 cytoplasmic, oxidation sensitive, cysteine residues (Xu et 
al. 1998). These cysteines have thiol side chains that are very sensitive to 
oxidization. When the thiols are oxidized, intra-molecular cystines or cysteine-
oxidizer adducts can be formed. It has been shown that some of the thiols on the 
RyR activate the channel when they are exposed to oxidizing conditions and that 
some of the thiols inhibit the channel when oxidized. (Jonathan J. Abramson and 
Guy Salama 1988; Jonathan J. Abramson and Guy Salama 1989; A. Dulhunty et 
al. 2000). To maintain proper cell function, the redox potential of the muscle cell 
environment is kept in a tightly controlled and reduced state by the relative ratios 
(redox couple) of a few important endogenous compounds capable of cyclic 
redox states. The redox state of the cellular environment can be impacted by all 
of the cellular redox couples present with each couple contributing via an additive 
effect. However, due to its high concentration and respective reducing capacity, 
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the glutathione disulfide/glutathione (GSSG/2GSH) couple is considered to be 
the main redox buffer of the cell and the state (value) of this couple alone is 
typically used as an indication of the state of the redox environment of the cell 
(Schafer and Buettner 2001). The relative concentration of GSH present in the 
cell, and consequently, the redox environment is impacted by the invasion of 
oxidative species. The main endogenous oxidative species are derivatives of 
either oxygen or nitrogen. In particular, oxidative free radical compounds, 
hydrogen peroxide, and derivatives of nitric oxide. These are commonly referred 
to as reactive oxygen species (ROS) or reactive nitrogen species (RNS). ROS 
are natively generated and released from the oxidative phosphorylation 
processes of the mitochondria in the cell and by other mechanisms such as 
xanthine oxidase (XO) and NAD(P)H oxidases. ROS can impart their damage by 
further increasing ROS levels via autoxidation reactions that further increase the 
levels of oxidants by directly attacking and altering (taking or donating electrons) 
cellular membranes and proteins causing altered function (Sen and Packer 2000). 
Increased levels of ROS can be generated during increased levels of exercise, 
exposure to environmental pollutants, and consumption of pro-oxidant 
compounds in food and beverages. In order to keep the redox environment 
tightly controlled (and in a reduced state), the body has a host of endogenous 
antioxidant defenses against these oxidants. Antioxidants are tasked with 
neutralizing the ROS by donating or accepting electrons or hydrogens to or from 
the ROS minimizing or nullifying its reactivity before the ROS reaches critical 
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cellular substrates. In doing so, the antioxidant generally becomes a radical 
species itself but one that is more stable and relatively unreactive as compared 
to the original ROS. The main endogenous antioxidant compounds of the cell are 
glutathione (GSH), the glutathione peroxidase system, CoEnzyme Q, superoxide 
dismustase (SOD), and catalase. This defense network is effective at protecting 
against various ROS under normal cell conditions but high levels of oxidants, 
generated during times of high oxygen consumption (strenuous exercise) or as a 
result of prooxidant intake (air pollutants or high fat diets), can overwhelm the 
endogenous defenses. These increased levels of oxidant compounds can easily 
overwhelm the endogenous antioxidants inducing a state of oxidative stress in 
the cell (M. J. Davies and Dean 1997; Fridovich 1978; K.J. Davies et al. 1982).  
 
1.2 Oxidative Stress and Disease 
It is now well accepted that elevated ROS levels are associated with numerous 
bodily disease states including numerous cardio vascular diseases including but 
not limited to  atherosclerosis pathology (Khatri et al. 2004), cardiac hypertrophy 
(Higuchi et al. 2002), and myocardial lipotoxicity (S. Sharma et al. 2004). It is 
also connected with a variety of cancers, Alzheimer’s Disease, inflammatory 
diseases (Hidalgo and Donoso 2008; Zima and Blatter 2006; Belevych et al. 
2009) as well as skeletal muscle fatigue and failure (Moopanar and David G 
Allen 2005). Lipid peroxidation and sulfhydryl group oxidation during ischemia-
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reperfusion can lead to abnormally high cell Ca2+ levels and contractile 
dysfunction (Dhalla et al. 1999). Improper Ca2+ handling in the heart muscle has 
been connected to atrial arrhythmogenesis and contractile dysfunction in dogs 
with congestive heart failure (CHF) (Yeh et al. 2008). Evidence has shown that 
reactive oxygen species (ROS) alter calcium pump function (Kourie 1998; Kaplan 
et al. 2003), alter calcium current reduction in L-type calcium channels (Guerra et 
al. 1996), and decrease contractility via altered calcium handling (He et al. 2003) 
in cardiac myocytes. Recently, there have been numerous studies pointing to 
Ca2+ overload via improper Ca2+ handling by the RyR as an underling cause of 
arrhythmias and sudden cardiac death (Belevych et al. 2007; Belevych et al. 
2009).  
 
1.3 The Flavonoid Antioxidant – Calcium Homeostasis Connection 
 
Figure 1.2 Structure of Quercetin 
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The effects of flavonoid compounds on the activity of the RyR need to be 
evaluated before they can be considered viable nutraceuticals. These 
compounds may be good antioxidants and even promote anticancer effects but if 
they or their radical species react directly with the RyR or other Ca2+ homeostasis 
associated proteins, they may cause harmful calcium overloading effects.  
Studies on the interaction of flavonoids with the RyR are sparse. However, one 
popular flavonoid antioxidant, quercetin, has been shown to activate Ca2+ release 
from the SR skeletal muscle (D. H. Kim, Ohnishi, and Ikemoto 1983). Quercetin  
is a popular dietary antioxidant found in numerous vegetables, fruits, nuts, and 
teas. It has been extensively studied due to its excellent antioxidant properties 
and inclusion in numerous foods. Lee et. al. (Eun Hui Lee, Gerhard Meissner, 
and Do Han Kim 2002) showed that quercetin activates single RyR channel open 
probability (EC50 of 91.0 +/- 15 µM at 10 µM Ca
2+) more effectively than the well 
known RyR activator caffeine (EC50 of ~2.93 mM at 10 µM Ca
2+). Quercetin also 
exhibited a higher maximal open probability (Po=0.89 at 250 µM) as compared to 
caffeine (Po=0.66 at 9 mM). Quercetin is effective at stimulating the RyR but it 
didn’t exhibit any inhibitory actions. With regards to the redox sensitivity of the 
RyR, further tests were conducted to assay the effects of quercetin in the 
presence of the reduced and oxidized forms of glutathione (a cellular redox 
couple and as well as an endogenous antioxidant). The results showed that the 
effects of 5 mM GSSG (a RyR1 stimulant) plus quercetin on the RyR1 were not 
reversed by mM GSH (a known RyR1 inhibitor (Anthony C Zable, Terence G 
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Favero, and Jonathan J Abramson 1997)). This may indicate that quercetin does 
not work via a redox dependent pathway. They also showed that the known 
stimulatory effects of K+-ATP on the RyR partially inhibited the stimulation by 
quercetin indicating that they may share the same binding site or that the effects 
of ATP on the channel may allosterically affect quercetin binding. These results 
are interesting from the stand point that quercetin appears to have a direct effect 
on the RyR yet not via a redox pathway.  This is surprising since quercetin has a 
catechol group (ortho hydroxyls) on its B-ring which is notorious for being 
oxidized to semiquinone radicals and quinones which have prooxidant properties 
and directly react with protein thiols (Metodiewa et al. 1999; Boots et al. 2003). 
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1.4 The Anthocyanidins 
 
Figure 1.3 Anthocyanidin Structure 
Anthocyanidins are a subclass of flavonoids and are best known for the beautiful 
colors they impart to nature. Based on their simplicity and wide ranging 
abundance, the anthocyanidins delphinidin (Dp), cyanidin (Cy), and pelargonidin 
(Pg) are considered the three main anthocyanidins of more than 500 that are 
known to exist. They are responsible for most of the intense oranges, reds, blues, 
and purple colors exhibited in leaves, flowers, and fruits (J. B. Harborne, T. J. 
Mabry, and H. Mabry 1975). The chemical and biological properties of these 
compounds are very complex. Unlike other flavonoids, anthocyanidins are 
structurally unstable in weakly acidic to alkaline solutions. Upon exposure to 
these conditions, they will immediately start to transform into several different 
structural forms each with distinct chemical properties. The relative proportions of 
these forms is dependent on the pH of the solution and the specific 
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functionalization of the compound (Brouillard and Delaporte 1977; Brouillard and 
Dubois 1977; Brouillard, Iacobucci, and Sweeny 1982; Jurd 1963; Jurd and 
Geissman 1963; Jurd 1964; Jurd and Waiss 1965) (for more information see 
chapter 3). Along with the possible health benefits previously mentioned, these 
anthocyanidins are interesting and commercially valuable due to their ability to 
act as food colorants and food preservatives (antioxidants).   
1.4.1 Pelargonidin and Delphinidin – The Antioxidants 
 
Figure 1.4 Structures of pelargonidin and delphinidin 
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Although both pelargonidin (Pg) and delphinidin (Dp) exhibit good antioxidant 
properties as compared to the well accepted antioxidant vitamin E, delphinidin is 
dominantly superior to pelargonidin as an antioxidant. Delphinidin’s antioxidant 
quality is attributed to its tri-hydroxyl structure in its B-ring. Those groups are very 
easily oxidized and its mechanism of antioxidant action is probably by electron 
donation and formation of a semiquinone moiety. The donation of a second 
electron then will form a quinone. (S. A. Van Acker et al. 1996; A. Sekher 
Pannala et al. 2001). Pelargonidin only has a mono-hydroxyl B-ring and is a less 
effective antioxidant. Its mechanism of action is probably by donation of an 
electron and subsequent formation of a phenoxyl radical (Galati et al. 1999; 
Ananth Sekher Pannala et al. 2001).  
Both Pg and Dp exhibit superoxide and hydroxyl scavenging activity and can 
inhibit  hydrogen peroxide induced lipid peroxidation. In a study of pomegranate 
extract, a hypoxanthine-xanthine oxidase superoxide generating system where 
DMPO-OOH spin adducts (indicator of superoxide concentration) were measured 
by ESR, Dp and Pg both exhibited scavenging properties with Dp being over two 
orders of magnitude better than Pg (IC50=0.8µM and 130µM respectively). They 
also scavenged hydroxyl radicals with Dp being more effective than Pg although 
their scavenging properties may involve indirect rather than direct scavenging 
and possibly by more than one scavenging mechanism (Noda et al. 2002)  
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Dp and Pg also were shown to inhibit H2O2 induced lipid peroxidation in rat brain 
homogenate when H2O2 and Dp and Pg were incubated together with the brain 
substrate for 60 minutes (IC50=0.7µM and 85µM respectively) (Noda et al. 2002). 
In a similar extract study (grape seed, etc), Dp and Pg also exhibited (with one 
exception) scavenging properties for superoxide, hypochlorite ion, hydroxyl 
radical, and linolenic acid with Dp, again, being a better scavenger in all cases. 
Pg did not exhibit superoxide scavenging properties in this study (Wada et al. 
2007). 
Another study assessed the ability of Pg and Dp to scavenge the DPPH (1,1-
Diphenyl-2-Picrylhydrazyl) radical (4 min incubation in MeOH), prevent MeLo 
(Methyl Linoleate) emulsion (10% oil in water) hydroperoxide formation after 72 
hours (pH~5.5), inhibit Cu initiated hexanal formation from oxidation of LDL (2 hr 
incubation @ pH7.4), and prevent bulk MeLo (100%) hydroperoxide formation 
after 72 hours. Generally, Pg and Dp both exhibited antioxidant activity with Dp 
being a better antioxidant. However, at a low concentration (2.5µM), Dp exhibited 
prooxidant activity but Pg was still an antioxidant in the LDL assay. They 
attributed the better antioxidant property of Pg to the fact that it has low polarity 
and thus may have better access to the lipid peroxidation site of the LDL (they 
sited similar results from another study). The researchers also admitted that the 
method of antioxidant action at higher concentrations may be due to hydrogen 
donation to the tocopheryl radical back to tocopherol (vitamin E) or by 
scavenging radicals and protecting tocopherol from consumption. Additionally, 
 16
the anthocyanidins may bind with apolipoprotein B and prevent its subsequent 
binding to LDL thus blocking Cu catalyzed oxidation. Interestingly, they also 
noted that polar antioxidants (hydrophilic) are generally are more efficient in bulk 
oils than non-polar antioxidants (hydrophobic). This is due to a higher 
concentration or accumulation of a hydrophilic compound that accumulates at the 
oil water interface (Kahkonen and Heinonen 2003). 
The radical scavenging ability of Pg and Dp is pH dependent. In a study by 
Borkowski et al., the TEAC antioxidant values (antioxidant action relative to 
Trolox) are measured for Pg and Dp (and several other anthocyanidins). The 
TEAC assay is based on the ABTS*+ radical and the ability of the antioxidant to 
scavenge it and thus reduce its characteristic absorption spectrum. This 
particular compound was used due to its stability in a wide range of pHs. (2-9.5). 
Results basically indicated that Dp is a powerful antioxidant (several times better 
than Trolox) and its increase in scavenging activity is related to the 
deprotonations of its C4’ hydroxyl (pKa1~5.3 (experimentally determined)) and its 
C5 hydroxyl (pKa2~6.73 (computationally predicted)). Pg on the other hand had 
an activity similar to Trolox but did not show a strong increase in activity with the 
deprotonation of C5.(pKa1~5.79 (experimentally determined)) and the 
deprotonation at C4’ (pKa2~7.05  (computationally predicted)) (Borkowski et al. 
2005). 
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1.4.2 Pelargonidin and Delphinidin – The Prooxidants 
As hinted at in the previous section, both Pg and Dp can exhibit prooxidant 
properties. Delphinidin’s pyrogallo group in its B-ring is highly oxidizable and 
autoxidation of this group is possible at physiological pH. Autoxidation is 
accompanied by generation of superoxide and hydrogen peroxide (Hodnick et al. 
1986; Hodnick et al. 1988). This property may also be enhanced by delphinidin’s 
metal chelating ability which is also known to catalyze the autoxidation of 
(similarly oxidizable) catechol groups (dihydroxy group) (Vanacker et al. 1995; 
Canada et al. 1990; Dangles, Fargeix, and Dufour 2000).  
Pelargonidin, with only a monohydroxyl group in the B-ring, does not exhibit 
autoxidation and doesn’t chelate metals. Its reduction in hydrogen peroxide 
induced lipid peroxidation activity may be due to a different oxidation mechanism 
(Saskia A. B. E Van Acker et al. 1996). In one study, it was found that the 
phenoxyl radicals of similarly structured compounds with a mono-hydroxyl 
substituted B ring redox cycled and caused extensive GSH oxidation at pH~7 to 
form thiyl- radicals which reduced oxygen. Surprisingly, flavonoids containing a 
catechol B-ring did not show the same oxidative properties (Galati et al. 1999). 
In a LDL oxidation assay (Satue-Gracia, Heinonen, and Frankel 1997), both Dp 
and Pg act as prooxidants when 3uM copper is used as an oxidation initiator. 
Interestingly, when 10µM copper is used, Pg acts as an antioxidant and Dp 
continues to be prooxidant. It was noted that more work was needed to be able 
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to propose a mechanism for why Pg changes its antioxidant/prooxidant activity 
with various copper concentrations. 
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1.5 This Thesis  
Due to the importance of understanding the effects that potential nutraceuticals 
have on the Ca2+ homeostasis in muscle tissue, this thesis will attempt to 
evaluate the modulation effects that pelargonidin and delphinidin have on the 
ryanodine receptor calcium release channel of skeletal muscle.  
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2 Muscle Structure and Function 
At a macro level, muscles are well defined organs capable of generating great 
force when stimulated to do so. Some of these stimuli are consciously controlled 
(voluntary muscle) and some are not consciously controlled (involuntary muscle).  
The heart (cardiac muscle), the iris of the eye, the arrector pili of the skin, the 
bladder, blood vessels, the gastrointestinal tract, are all examples of organs that 
contain involuntary muscle. Skeletal muscle is the only muscle tissue that is 
consciously controlled. It is responsible for locomotion, posture, voluntary eye lid 
movement, and sphincter control to name a few. Both cardiac muscle and 
skeletal muscle are classified as striated muscle due to the striated appearance 
of muscle fibers when viewed under the light microscope. These striations are 
due to a repeating, end-to-end, pattern of contractile proteins at the molecular 
level of the tissue. There are three types of muscle tissue: cardiac, skeletal, and 
smooth. They all have unique characteristics depending on the function for which 
they are designed. For instance, non-striated smooth muscle lacks the end-to-
end pattern of contractile proteins as mentioned. The random orientation and 
alignment of the contractile proteins of smooth muscle allows it to accommodate 
larger variations in stretch while still maintaining contractility. These 
characteristics are favorable in organs such as the bladder and the GI tract. On 
the other hand, the end-to-end and aligned orientation characteristics of skeletal 
and cardiac muscle allow them to generate large forces with longer contractile 
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distances. These characteristics are required for generating large movements 
like bending a leg and also for generating high fluid pressures within the heart 
ventricles.  
2.1 Muscle Structure 
The original work presented in this thesis is most closely related to the function of 
the calcium release channel of skeletal muscle and thus it will be the primary 
muscle tissue discussed. However, probably the most benefit to society can be 
obtained if these types of studies are applied to cardiac muscle. For that reason, 
the finer details of the function of cardiac muscle may also be discussed. Smooth 
muscle is also very important with regards to human anatomy and physiology, 
but due to the limited scope of this thesis, it will generally not be discussed. 
2.1.1 Skeletal Muscle Macro Structure 
Skeletal muscle is composed of both muscle tissue and connective tissue and is 
highly compartmentalized. Each compartment is contained and protected by 
fibrous connective tissue (epimysium, perimysium, and endomysium). The 
largest of these compartments contains the whole macro muscle (muscle belly) 
and is surrounded by the epimysium. The muscle belly is composed of fascicles 
which are many smaller bundles of parallel strands encased in the perimysium. 
The fascicles contain groups of the long muscle cell which also known as the 
myofiber. 
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2.1.2 The Muscle Cell Structure 
Skeletal myofibers span the complete length of the bulk muscle that contains it. 
They range from 10 µm to 100 µm in diameter and up to 30 cm long (depending 
on the macro muscle length). Due to their long shape, myocytes are also referred 
to as myofibers. Myofibers are surrounded by the endomysium which provides 
the fiber access to capillaries and nerves. Layered underneath and proximal to 
the endomysium is the cell membrane of the myofiber, the sarcolemma. The 
sarcolemma is the plasma membrane that contains the intracellular fluid of the 
myofiber called the sarcoplasm. The sarcolemma is designed to receive nervous 
system stimuli and conduct that signal throughout the cell via membrane 
invaginations (transverse tubules or T-tubules) that project directly into the 
cylindrically shaped cell at locations associated to the Z-disks of the sarcomere 
(contractile sub-unit of the myofiber). Internal to the sarcolemma are highly 
aligned and orientated filamentous motor proteins (myofibrils). Surrounding the 
myofibrils throughout the myofiber resides an organized and highly functional 
organelle network called the sarcoplasmic reticulum (SR). The SR is designed to 
act as a storage compartment for Ca2+ . The SR extends from T-tubule to T-
tubule and the group of organelles where two SR membranes from adjacent 
sarcomeres meet a t-tubule is called a triad (SR membrane: T-tubule: SR 
membrane). Proximal to the T-tubule, the SR exhibits an enlargement or sac 
which is referred to as the terminal cisternae (TC). The matrix of SR between the 
T-tubules and proximal to the longitudinal center of the myofibrils is the 
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longitudinal SR. The myofiber is composed of an end-to-end chain of many 
contractile sub-units called the sarcomere. The sarcomere is a highly organized 
and complex arrangement of numerous proteins. Filamentous actin (f-actin or 
thin filament) and filamentous myosin (f-myosin or thick filament) are the 
contractile proteins of muscle. Tropomyosin and troponin are the primary 
regulatory proteins. Additionally there are structural proteins that help maintain 
the form of the muscle cells. Titin is an elastic protein filament that runs through 
the center of the myosin filaments and emerges from the end of the filament to 
connect to the Z-disks proximal to each end of the filament. The Z-disks are 
composed of an elastic protein filament called connectin. The Z-disks are the 
highly light refracting portion of the fiber that gives rise to the striated appearance 
of the muscle. Z-disks provide direct anchorage for both the titin and the actin 
filaments. The area between two Z-disks that contains both f-actin and f-myosin 
is the sarcomere.  
2.1.3 The Sarcomere 
F-myosin filaments (thick filaments) are about 15 nm in diameter and are made 
of hundreds of motor proteins molecules, myosin II (hence forth referred to as 
just myosin). One molecule of myosin is comprised of two polypeptide chains 
intertwined to form a golf club shaped structure where one end is the tail and the 
other end the head. A myosin filament is several hundred of these golf club 
shaped molecules linked together end to end with the tail sections intertwined 
and the heads extending outward from the filament. Thin filaments are about 7 
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nm in diameter and are made up of two twisted strands of f-actin (filamentous 
actin). F-actin is a string like assembly of globular actin (G-actin) protein 
molecules. Each G-actin molecule has an active site that can bind to the head 
domain of the myosin molecules of F-myosin. Wrapped around the thin filament 
is another long polypeptide chain of proteins called tropomyosin. Tropomyosin 
has the function of blocking the binding of the myosin heads to the G-actin. 
Bound to the tropomyosin is a smaller and intermittently spaced calcium binding 
protein called troponin. Troponin has the function of binding calcium, undergoing 
a conformational change, and moving the tropomyosin filament which allows 
myosin to bind to the G-actin sites. Troponin has three sub-units and is bound to 
both the thin and thick filaments. The three sub-units are: TnI (bound to actin), 
TnT (bound to myosin), and TnC (calcium binding sub-unit).  
When the sarcomere is viewed under a light microscope, the varying densities 
and refracting properties of the protein structures can be observed, and thus 
distinguished.  The area spanning adjacent sarcomeres that includes the Z-disk 
but does not include the F-actin is called the “I Band”. The area that spans the 
length of one F-myosin filament is called the “A Band”, the area near the center 
of the F-myosin that does not overlap F-actin is called the “H zone”, and the area 
where the F-actin meets at adjacent sarcomeres is connected is called the Z-disk 
(as explained previously). The length of a sarcomere is approximately 1.7 µm in 
the contracted state and 2.2 µm in the extended state. The F-mysoin’s structure 
is such that the myosin heads orient themselves in a corkscrew shape along the 
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filament. This gives rise to a repeating pattern with six crossbridge head groups 
positioned in a radial pattern at multiples of 60 degrees. These repeating patterns 
are oriented such that the crossbridge heads align with each other along the 
length of the F-mysoin. F-actin and F-mysoin are orientated in hexagonal pattern 
when viewed as a cross section. There are six F-actin filaments surrounding 
each F-myosin filament, one F-actin per crossbridge head row and one F-actin 
filament may bind to more than one F-actin filament. This orientation is 
maintained throughout the myofiber which contains hundreds of myofilaments 
per fiber.   
2.1.4 The Sarcoplasmic Reticulum (SR) 
The SR is an organelle in the myocyte that has the primary function of storing 
Ca2+.  The SR is a webbed network of an enclosed membranous system 
extending along the length of each sarcomere. As previously noted, the SR has 
two main structural and functional regions: 1) the terminal cisternae are the 
enlarged sac like structures nearest to the T-tubules and 2) the longitudinal SR is 
located along the length of the sarcomere. The area where the TC meets the t-
tubule is highly functional and complex and it’s commonly referred to as the 
triadic junction, the dyadic junction, or (when referring to the SR specifically in 
this region) the junctional SR. The TC region of the SR contains a large amount 
of the Ca2+ binding protein calsequestrin. Calsequestrin is able to bind up to 50 
Ca2+ ions per monomer and this binding of free Ca2+ increases the total Ca2+ 
storage potential of the SR. The junctional SR is the home of the main regulatory 
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Ca2+ ion channel, the ryanodine receptor (RyR) (see next section more for 
additional detail) as well as other associated transmembrane proteins such as 
junctin and triadin. On the T-tubule, there resides a voltage gated Ca2+ ion 
channel called the dihydropyridine receptor (DHPR) which is also an important 
player in the functionally of muscle. Located primarily in the longitudinal SR is the 
Ca2+ ATPase pump (aka SERCA). There are almost 100 fold more SERCA 
pumps than RyRs in the SR. The Ca2+ ATPase is responsible for accumulating 
Ca2+ into the SR which allows the muscle to relax.  
 
2.1.5 Muscle Contraction 
The signal for a muscle to contract is sent from the brain via a neuron/axon to the 
neuromuscular junction. There, the signaling action potential opens voltage gated 
Ca2+ ion channels in the axon’s plasma membrane which causes the internal 
levels of Ca2+ to increase. The elevated Ca2+ causes intracellular vesicles 
containing acetylcholine (ACh) to fuse with the cell membrane and, through 
exocytosis, dump the Ach into the synaptic cleft. ACh then binds to ligand gated 
Na+ ion channels causing them to open and allow the subsequent influx of Na+ in 
to the cell. This process causes the immediate opening of K+ ion channels and 
the subsequent efflux of K+ out of the muscle cell. Because of concentration 
differences, more Na+ flows into the cell than K+ flows out of the cell and this 
causes an electrochemical depolarization across sarcolemma. This 
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depolarization self-propagates over the whole muscle cell and down the T-
tubules. The depolarization of the T-tubules signals for the opening of the 
resident voltage gated L-type Ca2+ ion channel, the dihydropyridine receptor 
(DHPR). In the skeletal muscle cell, the DHPR is believed to be mechanically 
coupled to the ryanodine receptor and the opening of the DHPR has shown to be 
the determinate cause of the opening of the ryanodine receptor. In cardiac 
muscle, the DHPR is not structurally associated with the ryanodine receptor. The 
opening of the DHPR allows Ca2+ to enter the cell from the cytoplasm. The 
process of Ca2+ influx through the DHPR and subsequent elevation in Ca2+ 
concentration is responsible for cardiac ryanodine receptor activation. This 
process is called “calcium induced calcium release”. The elevated levels of 
cytoplasmic Ca2+ causes Ca2+ binding to troponin which moves tropomyosin and 
allows myosin access to the actin binding sites. Myosin binding to the G-actin 
initiates the conformation change of myosin from a high energy conformation to a 
low energy conformation. This is commonly referred to as the power stroke. This 
change pulls the thin filament along the thick filament. The thin filament is 
attached to the Z-disks on each end of the sarcomere and the power stroke 
causes the sarcomere to shorten or contract. Thousands of these cellular 
contractions occurring in unison causes the muscle contraction we’re familiar 
with at the macro level. After the power stoke occurs, the low energy 
conformation of myosin remains attached to f-actin until an ATP molecule binds 
to it. If there isn’t any ATP available, the muscle remains in this contracted state 
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(rigor). If ATP is available, it binds to the myosin head and the head de-binds 
from actin. Once it is free, myosin can hydrolyze the ATP into ADP and Pi . The 
hydrolysis of ATP provides the energy for myosin to change back into the high 
energy conformation and then rebind to actin. This cyclic process is referred to 
as cross-bridge cycling. When the signal from the central nervous system stops 
initiating depolarizations of the cell membrane, the DHPR closes and the RyR 
closes as a result. Ca2+ concentrations are decreased and troponin changes its 
conformation to allow tropomyosin to block actin-myosin binding. This is the 
resting state of the muscle.  
2.1.6 Excitation-Contraction Coupling 
Excitation-Contraction Coupling (EC coupling) is the term used when describing 
the process of converting the cell depolarization into the actual muscle 
contraction. Although the overall process of the sliding filaments (sliding filament 
theory) is well established and accepted, the mechanism in which the DHPR 
communicates the depolarization signal to the RyR in skeletal dyads still remains 
uncertain. Cardiac dyadic junctions are organized differently than skeletal dyadic 
junctions. RyRs have the ability to self-organize into repeating patterns and do so 
in the junctional SR of both cardiac and skeletal muscle. Cryo-EM images of 
dyads have shown that the DHPRs of cardiac dyads are not arranged in any 
pattern with respect to the RyRs. They oppose the RyRs but in a random way. 
However, the DHPRs of skeletal dyads are arranged so that every other RyR1 is 
directly opposed to a cluster of four DHPRs and each cluster is associated with 
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one monomer of the RyR  (Block 1988). It has been shown that cardiac RyRs 
don’t require the interaction with the DHPR to release large stores of Ca2+ from 
the SR. Instead, fast increases of Ca2+ near the junctional SR causes Ca2+ 
release from the RyR. For this reason, the release of Ca2+ from the SR of cardiac 
SR has been characterized as calcium induced calcium release (CICR). For 
skeletal dyads, the mechanism is more complex. The highly organized 
arrangement between the DHPR and the RyR implies a high level of association 
between them and indeed it has been shown that in functional triads, the 
molecular modification of what is called the II-III loop or the DHPR can cause the 
RyR to cease to release Ca2+ from the SR. Studies of simpler protein complexes 
like the voltage dependent K+ ion channels have shown that cell membrane 
depolarizations trigger movements in voltage sensing domains and those 
movements can be trans-located across the membrane (Jiang, A. Lee, et al. 
2003; Jiang, Ruta, et al. 2003). Together with the organized DHPR-RyR1 
structures, it is hypothesized that charge dependent movements in the DHPR 
directly interact with the RyR and trigger the opening of the channel causing Ca2+ 
release. However, there are still a lot of unanswered questions stemming from a 
wealth of research and discussion and the understanding of the exact 
mechanisms required for EC coupling is still undetermined. 
2.2 The Ryanodine Receptor  
 Ryanodine receptors are the largest membrane ion channels known. Three 
mammalian RyR isoforms are known to exist. These include the skeletal muscle 
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RyR (RyR1), the cardiac muscle RyR (RyR2), and the smooth muscle RyR 
(RyR3). All of the isoforms have a sequence homology of approximately 70%. 
The skeletal RyR1 (rabbit) sequence consists of 5,037 amino acids and has a 
molecular weight of 565,223 Da. The complex is a homotetramer of four identical 
subunits with a total weight of ~2.3 MDa. 
2.2.1 The Ryanodine Receptor – Structure 
Knowing the ‘exact’ structure of a dynamically functional protein can give vast 
insight as to the biophysical mechanics and chemistry of the molecule. 
Unfortunately the RyR is too small to be viewed under a light microscope and too 
large and complex to solve with traditional structural techniques such as x-ray 
crystallography. Original freeze-fractured electron microscopy images of skeletal 
triads by Ferguson et al. (Ferguson, Schwartz, and C Franzini-Armstrong 1984) 
were among the first to show the square foot structure of the skeletal RyR. They 
also were able to show the significant association of the RyR and DHPRs in 
skeletal muscle (Clara Franzini-Armstrong and Kish 1995). Since then, cryo-EM 
of single particles has emerged as a very useful technique to study the structure 
of these particles. Utilizing fluorescent probes with EM can also give us an idea 
of where important modulators bind on the macro structure. Sample preparation 
includes solubilizing the protein with detergent to separate it from the SR and 
then freezing it in liquid ethane (~ -88oC). Many images (1,000 to 100,000) are 
computationally aligned and averaged and screened for artifacts to obtain the 
final result. Since the proteins have many different orientations, images from 
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different perspectives are obtained and images can be reconstructed to produce 
3-D images (Serysheva, Chiu, and Ludtke 2007). Capturing images of different 
conformational states is also possible by putting the RyR in an environment that 
favors a particular conformation prior to freezing it. Sub-nanometer resolutions 
have now been achieved by several groups (Ludtke et al. 2005; Serysheva et al. 
2008; Serysheva et al. 2007) and it has been shown by some of these same 
groups that resolutions of 6-10 Å  is adequate for determining secondary 
molecular structures (α-helices and β-sheets).  
2.2.2 Sub-nanometer cryo-EM Structures 
The RyR has a mushroom shape with a large cytoplasmic (CY) head and a 
smaller transmembrane (TM) stem. From above it has four-fold symmetry 
(quatrefoil shaped). The CY region is 280 Å x 280 Å x 120 Å with the 120 Å being 
the dimension from the SR membrane to the top of the channel. The CY region is 
of low amino acid density and shows numerous possible locations for ligand 
binding. The TM region is much more dense and has dimensions of 120 Å x 120 
Å x 60 Å. The orientation of the TM region is rotated approximately 40 degrees 
with respect to the CY region (Ludtke et al. 2005). At the corners of the CY 
structure, there are clamp shaped regions. These ‘clamps’ are connected to 
central rods by dense bridging structures. Images have been captured with the 
channel in both open and closed states. When going from the closed to the open 
channel state, conformational changes are apparent with: the removal of amino 
acid density in the center of the channel (pore opening), CY clamps change from 
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a closed shape to an open clamp shape, the TM domain rotates relative to the 
CY domain by ~4 degrees, and mass movements are seen in the central cavity 
and TM region (Orlova et al. 1996; Serysheva et al. 1999). The binding sites of 
several channel modulators have been mapped to the RyR structure by 
fluorescent tagging techniques. Calmodulin (Samsó and Wagenknecht 2002), 
FKBP12 (Samsó, Shen, and P. D Allen 2006), and other ligand binding sites 
have been located in the distal CY structure between clamp regions (‘handle’ 
region). Additionally, RyR mutations associated with malignant hypothermia and 
central core disease are known to be within the clamp region. This information 
supports beliefs that the channel is gated by allosteric means.   
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Figure 2.1 Cryo-EM reconstruction of RyR1 in open and closed states (Orlova, E. et al. 
Nature Structural Biology v3(6) 547-52. 1996) . 
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2.2.3 The Ryanodine Receptor Function 
2.2.3.1  Associated Proteins and Endogenous Modulators of the RyR 
Dihydropyridine Receptor (DHPR): The DHPR is an L-type voltage gated Ca2+ 
ion channel located in the T-tubule membrane of the dyadic junction. It is highly 
associated with RyR1 both from a structural organization relationship and in 
function. It is the primary Ca2+ release initiator and is required for proper RyR1 
function. The DHPR is less associated with RyR2. The structural organization is 
lacking and a direct interaction with the DHPR is not required for RyR2. 
FKBP12/12.6: FKBP12 is a 12kDa protein associated with the RyR1 (FKBP12.6 
is associated to RyR2) and binds in the ‘handle’ region at a ratio of four FKBP 
molecules per RyR (one FKBP per monomer). FKBP12 stabilizes the RyR and 
disassociation of FKBP from the RyR causes an increase in Ca2+ conductance.  
Calcium: The RyR is a Ca2+ activated Ca2+ channel. The response of the RyR to 
free Ca2+ concentration is bell shaped. Ca2+ conduction through the RyR is 
minimal at low (<1 µM ) concentrations, maximal ~100 µM (depending on 
conditions), and again minimal above 1000 µM free Ca2+ (J.S. Smith, Coronado, 
and G. Meissner 1986). This type of behavior is typically attributed to more than 
one binding site with each binding site having either differing ligand affinities or 
conformational accessibility limitations. Due to the small size of Ca2+, the 
accessibility option is probably not a concern. Therefore, the belief is that there is 
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a high affinity activating binding site that gets populated at low Ca2+ 
concentrations and a low affinity inhibition binding site is populated at high Ca2+ 
concentrations.  
Calmodulin (CaM): CaM is a Ca2+ binding protein with a molecular weight of 
16.8 kDa. CaM’s structure is made up of four Ca2+ binding domains (EF-hands) 
and it can bind four Ca2+ ions per protein. It is known to bind with RyR1 and 
cause stimulation at low Ca2+ concentrations and inhibition at high Ca2+ 
concentrations. Binding with RyR2 causes only channel inhibition (J. S Smith, 
Rousseau, and G. Meissner 1989; Tripathy et al. 1995).  
Magnesium (Mg2+): Mg2+ is a known inhibitor of the RyR. Due to its similar 
nature and size as compared to Ca2+, it is believed that Mg2+ may compete with 
Ca2+ for the high affinity inhibition sites which is believed to cause inhibition of the 
channel with high concentrations of Ca2+ (J.S. Smith, Coronado, and G. Meissner 
1986). 
Adenosine-5'-triphosphate (ATP): ATP as well as other adenine nucleotides 
(cAMP, ADP, AMP, etc) are stimulators of the RyR (G. Meissner, Darling, and 
Eveleth 1986). 
Glutathione (GSH): GSH is a tri-peptide of glutamate, cysteine, and glycine. 
GSH is a good reducing agent and is one of the principle endogenous 
compounds tasked with keeping the cellular redox status in check. Its 
concentration in the cell varies between 1 mM and 10 mM. When in an oxidizing 
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environment, it can be oxidized and form  glutathione disulfide (GSSG). GSH 
(reduced form) inhibits the RyR and GSSG (oxidized form) stimulates the RyR. 
The two forms show to be competitive and therefore it is believed that they both 
act on the same regulatory sulfhydryls on the RyR. (A C Zable, T G Favero, and 
J J Abramson 1997) 
Superoxide (O•– ): Superoxide is commonly generated by leaks in the ETC 
(electron transport chain) pathway of the mitochondria in cells and is a major 
contributor to oxidative stress. Superoxide has shown to decrease calmodulin 
content and increase Ca2+ efflux from heavy SR. It was also shown that single 
channel activation was dependent on the presence of calmodulin. (Kawakami 
and Okabe 1998) 
Hydrogenperoxide (H2O2): H2O2 was shown to induce release from actively 
loaded SR vesicles at >1 mM concentrations and induce a bi-phasic response in 
[3H]-ryanodine binding assays (activation range: 100 µM – 10 mM). (T G Favero, 
A C Zable, and J J Abramson 1995)  
Junctin and Triadin: Junctin is a ~27kDa MW membrane protein and Triadin is 
a 95kDa MW membrane protein (Fan, Brandt, and Caswell 1995). Junctin and 
Triadin both bind to the RyR and are believed to help associate calsequestrin to 
the RyR (J. M Lee et al. 2004; Goonasekera et al. 2007; Jones et al. 1995; 
Angela Dulhunty, Lan Wei, and Nicole Beard 2009). They both have been shown 
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to activate the RyR when added to the luminal side of the channel and seem to 
activate at independent sites (L. Wei, Gallant, et al. 2009). 
Calsequestrin (CSQ): CSQ is a 44 kDa Ca2+ binding protein located in the 
lumen of the SR that effectively binds up to 50 Ca2+ ions per molecule 
(MacLennan and Wong 1971). CSQ has been found to increase channel activity 
when removed from the of RyR complex and inhibit activity when added back in 
to the luminal space (N. A Beard et al. 2002). There are two CSQ genes, CSQ1 
(fast and slow twitch skeletal muscle) and CSQ2 (slow twitch skeletal and 
cardiac). Single channel studies have shown that CSQ1 may inhibit RyR1 but 
stimulate RyR2 (L. Wei, Hanna, et al. 2009)  It should be noted that numerous 
studies of the interaction between RyR, CSQ, junctin, and triadin are being 
reported in current literature and important and relevant information regarding the 
interaction of these protein complexes are being discovered. 
2.2.3.2  Non-Endogenous Modulators 
Ryanodine (Ry):  Ryanodine is an alkaloid found in the plant Ryania speciosa of 
South America. It has a high affinity to the RyR (and thus the reason for its name) 
and locks it in a varying degree open state depending on concentration. (I. N. 
Pessah et al. 1986; Lai et al. 1988). 
Ruthenium Red: Ruthenium is a potent channel inhibitor and can block channel 
activity at sub micromolar concentrations. It is commonly used to verify the 
presence of the RyR in assays (Ma 1993). 
 38
4-chloro-m-cresol (4-CmC): 4-CmC a drug preservative stimulates (~75-100 
µM) [3H]-ryanodine binding and planar bilayer activity. (Herrmann-Frank et al. 
1996) 
Anthraquinones: Doxorubicin, mitoxantrone, daunorubicin, and rubidaxone all 
stimulate RyR1 activity by a direct interaction with the caffeine and the Ca2+ 
binding sites.  (J. J. Abramson et al. 1988) 
2.2.3.3 Redox Activity Characteristics 
The RyR has approximately 100 cysteines per monomer (Takeshima et al. 1989) 
with approximately 80 of those accessible to be oxidized. Cysteines are highly 
reactive and well known to be redox active compounds in other biological 
molecules. The RyR has also been shown to be very sensitive to its redox 
environment. When the RyR is subject to an oxidizing environment, the RyR is 
stimulated, when the oxidizer is pre-treated with a reducing compound (DTT), the 
oxidizer loses its stimulating capability.  (Jonathan J. Abramson and Guy Salama 
1989; Jonathan J. Abramson and Guy Salama 1988; Carnes et al. 2009; Marinov 
BS and J.J. Abramson 2005; Xia, Stangler, and J. J Abramson 2000; Anthony C 
Zable, Terence G Favero, and Jonathan J Abramson 1997; J.J. Abramson et al. 
1983; A. Dulhunty et al. 2000).   
Redox active compounds that have shown to modulate the RyR include: 
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 Heavy Metals (Hg2+, Ag+, Cu2+, Cd2+, Zn2+): Heavy metals bind with high affinity 
to protein sulfhydryl groups and activate the ryanodine receptor at low 
micromolar concentrations (J. J. Abramson et al. 1983). 
Phtalocyanine Dyes: Oxidation by the phthalocyanine dyes (alcian blue (AB), 
Cu2+ phthalocyanine tetrasulfonic acid, and Luxol fast blue MBSN) were found to 
induce rapid Ca2+ release from actively (Ca2+ ) loaded SR. Pre-reduction of AB 
with reducing agents causes loss of stimulating effect indicating that the 
compounds are acting via redox sensitive interactions with the RyR. (J. J 
Abramson, Cronin, and G. Salama 1988) 
Quinones : Naphthoquinone and benzoquinone have been shown to activate 
channel activity by oxidation of hyperactive cysteine thiols on the RyR1 and 
RyR2 (Feng et al. 1999). 
Coumarin maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-
methylcoumarin (CPM) : CPM (1-50 nM) binds to RyR-triadin hyper-reactive 
thiols when RyR is in a closed state. Covalent interactions of those thiols with 
nanomolar CPM inhibits gating activity. (G. Liu et al. 1994) 
1,4-Napthoquione: 1,4-Napthoquione (0.4-40pmol/µM) oxidizes hyperactive 
thiols on RyR-triadin and stimulates Ca2+ release from SR vesicles. (G. Liu et al. 
1994) 
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3 The Anthocyanidins:  Pelargonidin and Delphinidin 
3.1 Anthocyanidins 
 
Figure 3.1 Basic Structure of Anthocyanidins 
 
Anthocyanidins are one of the six sub-classes of Flavonoids (itself being a sub-
class of polyphenols). They are compounds of the plant kingdom that have the 
general structure of a flavylium cation (2-phenylchromenylium) with a C6C3C6 
skeleton and with functionalization occurring at specific locations on the structure 
(see Figure 3.1). Functional groups are typically referred to by the number of the 
carbon to which it is attached (eg. The C4’ hydroxyl or the 4’-OH). Additionally, 
the compound is sometimes characterized by its individual aromatic rings A, B, 
and C. Anthocyanidins are salts and usually are identified along with a chloride 
counter ion. The counter ion dissociates with the main molecule in solution which 
leave a positive charge on the compound. This charge allows anthocyanidins to 
absorb light and exhibit intense colors from the orange-reds to the purples. They 
provide most of the red to purple colors observed in flowers, leaves, fruits, and 
 41
vegetables. They share a common function in the phyto-kingdom as pigments 
used to attract insects for pollination, cellular signaling molecules, anti-fungal 
protection, and UV light protection. Specific anthocyanidins are identified by how 
the base structure is functionalized with hydrogens, hydroxyl, methoxy, and 
sugar groups and the amount and type of substitution contributes greatly to the 
color properties of the molecule. There are 23 known anthocyanidins (Øyvind M. 
Andersen and Markham 2006). Anthocyanidins have poor solubility in aqueous 
solutions but when sugar groups are attached (anthocyanins), they become more 
soluble and as such, that is the form that is found most in nature with more than 
500 known anthocyanins documented. Although anthocyanins are the more 
prevalent, the functional properties of those compounds are due to the aglycon 
form (anthocyanidin) and thus most studies focus on that group of compounds 
(Estevez and Mosquera 2008; J. B. Harborne, T. J. Mabry, and H. Mabry 1975).  
The six anthocyanidins that are considered to be the most important mainly due 
to their widespread distribution in nature are pelargonidin, cyanidin, delphinidin, 
petunidin, peonidin, and malvidin. Three of these six are considered to be the 
principle anthocyanidins due to their minimal substituent groups: delphinidin (Dp), 
cyanidin,  (Cy),and pelargonidin (Pg). These three all have the same hydroxyl 
functionality on the 3, 5, and 7 carbons of the A and C rings. They differ in the 
amount of hydroxyl groups on the B-ring. The addition of hydroxyl groups to the 
B-ring (R2=OH for pelargonidin, R2=R3=OH for cyanidin, and R1=R2=R3=OH for 
delphinidin) causes a bathochromic (red) shift in their absorption spectrum. They 
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have absorbance maxima at 530nm, 545nm, and 556nm (respectively) when 
prepared in acidified ethanol (Cabrita, Fossen, and Øyvind M. Andersen 2000).  
3.2 Anthocyanidin Structural Equilibrium 
Anthocyanidins are native to the acidic conditions of the plant cell. Under these 
conditions, the anthocyanidins predominately occur in the ‘flavylium cation’ form 
as shown in Figure 3.1. Upon placing them in a more alkaline aqueous 
environment, they become very unstable and their structure is altered in various 
ways depending mainly on the pH but temperature and light can also be effectors. 
At very acidic pH, anthocyanidins exist almost exclusively in the flavylium cationic 
form (AH+) (see Figure 3.2).  When subjected to higher pHs (~5), anthocyanidins 
exhibit three distinct chemical reactions involving proton transfers, hydration, and 
tautormerizations. Upon a pH jump to ~5, deprotonation immediately occurs on 
the hydrogen (or hydrogens) of the flavylium cation with the lowest bond 
disassociation enthalpy (BDE) resulting in the quinoidal base form (A) or the 
quinoidal base anion form (A-). The flavylium cation (AH+) and the quinoidal base 
(A) quickly (<1 sec) come to an equilibrium. On a slower time scale (minutes to 
hours), AH+ undergoes hydration to obtain the carbinol pseudobase (B) and/or 
the carbinol pseudobase anion (B-). The rate of these reactions are dependent 
upon the pH of the environment and on the degree and type of substitutions. 
Higher pH generally leads to a slower transformation to the carbinol form 
(Brouillard and Delaporte 1977; Brouillard and Dubois 1977). This will depend on 
the pKa’s of the substituents of the different anthocyanidins. In addition, the 
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quinoidal base transforms to the colorless carbonyl pseudobase (C) form. For 
cyanidin (the only kinetic study of a related  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 The forms of pelargonidin in neutral pH solutions  
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anthocyanidin that I found in literature), the half life of this structural 
transformation is reported to be 0.5 days (at pH 2.8) (Iacobucci and Sweeny 
1983).  
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3.3 Pelargonidin 
 
Figure 3.3 Molecular Structure of Pelargonidin 
 
Pelargonidin (Figure 3.4) was first obtained by Willstater and Bolton in 1914 by 
the hydrolysis of pelargonin of Pelargonium zonale. It has absorbance maxima in 
the 530nm (in EtOH-HCl). Pelargonidin is found in the skin of the red radish, 
strawberries, petals of geraniums, and the rose (among others). 22 glycosides of 
pelargonidin are known (J.B. Harborne 1967). Pelargonidin has hydroxyl (–OH) 
groups at the 3, 5, 7, and (para) 4’ positions. The structural configurations of 
pelargonidin are shown in Figure 3.3. When exposed to increasing pH conditions, 
compounds with a monohydroxylated B ring (pelargonidin) exhibit a gradual 
bathochromic (red) shift up to pH~6, an extensive red shift from pH~6 to pH~7.3, 
and a stable λmax  from pH7.3 to pH~10-11(Cabrita, Fossen, and Oyvind M 
Andersen 2000).  These color changes are caused by structural changes as 
mentioned in the previous sections. Although the first pKa (pKa1) can be 
determined experimentally, subsequent deprotonation pKa’s (pKa2 etc.) are 
difficult to determine experimentally due to the simultaneous existence of multiple 
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forms of the compound in solution. Thus, to predict the pKa of subsequent 
deprotonations of each structural form, quantum mechanical calculations 
determining the disassociation energies of each hydrogen must be performed. 
The lowest computed BDEs based on the lowest energy structures are 
considered the first to deprotonated. In reality, there may be several similarly 
valued low energy structures and several hydrogens with similar valued BDEs 
which imply a mixture of compounds in solution at all times. When subjected to a 
neutral pH environment, pelargonidin rapidly deprotonates and changes from the 
flavylium cation from to its quinoidal base form. The first deprotonation is 
experimentally been shown to be at pH 5.79. The favored deprotonation site as 
calculated numerically is the 5-OH group. The predicted pKa2 for the quinoidal 
base form is at pH 7.05 and located at the 4’-OH. At physiological pH (~7.4), 
pelargonidin is probably in an anionic quinoidal base form (see Figure 3.2). The 
transformation to the anionic quinoidal base is very fast coming with equilibrium 
in less than 1 second. A second transformation to the carbinol pseudobase has 
slower kinetics with a half life in the 10 minute range (see result section). The 
pKa2 for the carbinol form is predicted to be 8.35 and therefore is probably not 
anionic at the experimental pH of ~7.1-7.4. The structural change to the chalcone 
form is on order of 12-24 hours (data for cyanidin, not pelargonidin). The 
predicted pKa2 for the chalcone is 6.73 also at the 4’ position and therefore it is 
predicted to be in an anionic form (Borkowski et al. 2005) 
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3.4 Delphinidin 
 
Figure 3.4 Molecular Structure of Delphinidin  
 
Delphinidin (Figure 3.4) was first obtained by hydrolysis of delphin (of the 
larkspur (Delphinium consolida). It has an absorbance maxima of 556nm (EtOH-
HCl) and is responsible for rich purple and dark violet colors of berries. It is found 
in the skin of eggplant, grapes, and pedals of the hyacinth just to name a few. 
(J.B. Harborne 1967) 
Compounds with a trihydroxylated B-ring (delphinidin) show a gradual 
bathochromic (red) shift up to pH~6, an extensive red shift from pH6 to pH~7.3, 
an extensive blue shift from pH7.3 to pH~8.5, and then another red shift at even 
higher pH’s.  Due to the same (mixture of forms) difficulties as addressed in the 
pelargonidin section, the pKa2’s for  
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Figure 3.5 The forms of delphinidin in neutral pH solutions 
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delphinidin are also predicted numerically rather than experimentally. 
Delphinidin’s first deprotonation is at pH 5.30 (experimental) and numerical 
based deprotonation energies predict it to be the 4’ hydrogen. The predicted pKa2 
is at 6.73 at C5. At physiological pH, delphinidin is predicted to rapidly 
deprotonate to the quinoidal base anion form with lost hydrogens on 4’ and 5. 
The carbinol pseudo base has a predicted pKa2 on C4’ at 7.25 and thus may be 
in a mix of its neutral and anionic forms at physiological pH. The predicted pKa2 
for the chalcone form is 4.9 also at the 4’ position and therefore it is predicted to 
be in a neutral form as well (Borkowski et al. 2005).  
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4 Materials and Methods 
4.1 Sarcoplasmic Reticulum Vesicles 
Sarcoplasmic reticulum was isolated from fast twitch back and hind leg skeletal 
muscle extracted from 2-3 kg New Zealand white male rabbits according to the 
methods of MacLennan et al (1970) with modifications. Live rabbits were 
euthanized, bled, and put on ice. Removed muscle was also put on ice. Fat and 
red muscle was trimmed from the fast twitch muscle and discarded. Fast twitch 
muscle was cut to approximately 1 inch peices and placed into a cold proteolysis 
inhibiting buffer of 120mM NaCl, 10mM imidazole, 100µM DTT, 10µM EGTA, and 
100µM leupeptin at pH 7.4. Muscle was then homoginized with a common 
household blender (Waring) by a 4X repeating cycle of 15 sec at low speed, 60 
sec high speed, and 30 sec of no blending. Homogenate is then centrifuged at 
1,600×g for 10 minutes. Supernate is then filtered through four layers of 
cheesecloth to remove excess debris and fat. Remaining homogenate is 
adjusted to pH 7.4 with imidazole and centrifuged at 10,000×g for 15 minutes to 
remove mitochondria. Supernate is retained and centrifuged at 44,000×g for an 
additional 70 minutes to collect SR. Supernate is discarded and remaining pellet 
is homogenized to approximately 10mg/ml with a buffer of 120mM NaCl, 10mM 
imidazole, 100µM DTT, and 50µM EGTA at pH 7.4. The resulting homogenate is 
then centrifuged at 7,500×g for 10 min to remove any remaining myosin. 
Supernate is retained and centrifuged at 78,000×g to obtain the SR pellet. The 
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pellet is then homogenized to approximately 20mg/ml in a buffer of 100 mM KCl 
and 20 mM HEPES at pH 7.0. Aliquots of SR are put in cryo-storage tubes and 
stored in liquid N2 until needed. 
The protein concentration of the SR is then quantified by the method of Kalckar 
(1947). The 280nm absorbace of aromatic amino acids tyrosine and tryptophan 
combined with the 230nm absorbace of the peptide backbone can be utilized to 
determine the total protein concentration (see Equation 4.1). Equation 4.2 is a 
correction factor for the possible contamination of nuclecic acids which absorb at 
230nm. 
  
Equation 4.1  
 
/ 280 260[ ] 1.45 ( ) 0.74 ( )mg mlSR Abs Abs= × − ×  
  
  
Equation 4.2  
 
/ 230 260[ ] 0.185 ( ) 0.075 ( )mg mlSR Abs Abs= × − ×  
 
4.2 Reagents 
 
Ryanodine was purchased from CalBiochem (San Diego, CA), 3[H]-Ryanodine 
was purchased from Du Pont – New England Nuclear Co. (Boston, MA), 
Pelargonidin chloride (CAS#134-04-3) was purchased from Sigma Aldrich, 
Delphinidin chloride (CAS#528-53-0) was purchased from Sigma Aldrich and 
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Extrasynthese (France), Antipyrylazo III and A23187 was purchased from Sigma 
Aldrich,  EtOH was analytical grade 200 proof, anhydrous >99.5%, all water used 
has a resistivity of 18 Mohm and was obtained from a Mili-Q System (Millipore 
Co), all other reagents (buffers, salts, etc) were of typical laboratory grade unless 
noted.  
 
Pelargonidin and delphinidin were prepared at 10mM concentrations in EtOH and 
stored at ~-4oC between experiments.  
Stock solution was diluted to lower concentration in EtOH in necessitated by the 
experiment. 
 
4.3 Methods 
4.3.1  Passive Ca2+ Loading of SR Vesicles  
Ca2+ was passivily loaded into SR vesicles by incubating undiluted stock SR 
(~20mg/ml protein) in 0.5mM to 1mM CaCl2  by the procedure as follows. SR was 
removed from LN2 storage and thawed by rubbing between the hands until no 
solid SR particles were observed. Multiple storage tubes are thawed and 
combined as needed to obtain an amount nessesary for the experiment. An 
appropriate amount of 100mM CaCl2 is added to the SR and then vortexed for 3-
5 seconds. The tube is then plunged into LN2 and allowed to freeze solid for ~5-
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10 seconds. The tube is then thawed again as previously decribed and placed 
under crushed ice overnight.  
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4.3.2 Ca2+ Efflux Measurements 
Ca2+ release from SR vesicles can be monitored and quantified by 
spectrophotometric methods utilizing polycationic indicator dyes that change 
absorbance with corresponding changes in sample free Ca2+ concentration 
(Scarpa, Brinley Jr, and Dubyak 1978). The polycationic indicator dye 
Antipyrylazo III (APIII) and a time sharing dual wavelength spectrophotometer 
(Chance et al. 1975) (purchased from the University of Pennsylvania) was 
utilized for all efflux experiments. The spectrophotometer is a rotating wheel type 
with bandpass filters that pass 720nm and 780nm wavelengths from a halogen 
source. The passed wavelengths are incident on a photomultiplier tube which is 
connected to a multiplexing amplification control module. The control module 
conditions the signals by taking the difference between the (Ca2+ responsive) 
780nm signal from the (Ca2+ non-responsive) 720nm signal. The difference is 
then output as an analog voltage signal, digitized, and recorded on a PC 
(AxoScope software, Axon Instruments (now Molecular Devices)).  An APIII 
buffer containing 100mM KCl, 20mM HEPES, and 200µM APIII at pH 7.4 was 
used. SR vesicles were loaded with Ca2+ as previously described.  A typical 
experiment involves 2 ml of the APIII buffer added to a 4.5ml polystyrene cuvette 
with 1cm path length and a magnetic stir bar. Approximately 40µl-50µl (0.4-0.5 
mg/ml final protein concentration) of prepared SR is pipetted into the APIII buffer. 
The intravascular Ca2+ concentration is now approximately 50-40 fold greater 
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than the extravesscular Ca2+. The concentration gradient forces release of Ca2+ 
through the channel. APIII’s spectrum changes in response to the rising Ca2+ 
concentration and the resulting signal change is recorded for further analysis. At 
the completion of a Ca2+ efflux experiment, the Ca2+ ionophore A23187 is added 
(2 µl @ ~1.0 ug/ml) to initiate release of all unreleased intravesscular Ca2+ (to 
determine total vesicle loading capability and to assist in data analysis). A known 
amount (~5 µM) of CaCl2 can also be added for Ca
2+ signal calibration. To assay 
for the effect of possible modulators, the modulator is added immediately (<1 sec) 
prior to the addition of the SR. The resultant signal is compared to the signal of 
the contro. To ensure that the increasing Ca2+ signal is from Ca2+ leaving the 
RyR1, the potent inhibitor Ruthenium Red is added immediately prior to the SR. 
Ruthenium Red control should block the release of Ca2+ from the SR vessicles.  
To quantifiy the results, the data representing the Ca2+ release phase is fit to a 
first order exponential rise to max equation (Sigma Plot). Typically, the initial rate 
of Ca2+ release is calculated by taking the product of the value of maximum 
amount of Ca2+ released (µM) and the rate constant (s-1) which gives the initial 
rate of Ca2+ in units of µM/s. The initial rate of Ca2+ release is then compared. 
It was verified that Pg and Dp do not significantly alter the Ca2+ response of APIII. 
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4.3.3 Ryanodine Binding 
 
4.3.3.1 Ryanodine 
 
Ryanodine (Figure 4.1) is an alkaloid found in the plant Ryania speciosa of South 
America. It has a high affinity to the RyR and locks it in a varying degree open 
state depending on concentration. Due to it’s specific affinity to the RyR and it’s 
use as a label for the first purification of the RyR, the RyR is commonly known as 
the ryanodine receptor.  
 
 
Figure 4.1 Molecular Structure of Ryanodine 
 
The rate of ryanodine binding to the RyR depends on the open probablility of the 
RyR. The higher the open probability of the RyR, the greater the rate of Ry 
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binding. By using tritiated ryanodine, the amount of rayanodine that binds to the 
RyR in a specidfied amount of time can be quantified by a scintillation counter 
and be indirectly used to the open state of the RyR. The Beckman LS6500 
scintillation counter is utilized for this purpose.  
 
4.3.3.2 Binding Assays 
SR (0.5 mg/ml) is combined with a standard ryanodine buffer of 250mM KCl, 15 
mM NaCl, and 20 mM HEPES at pH 7.1. [
3H]-ryanodine is added to obtain a final 
[3H]-ryanodine concentration of 2 nM. Mixtures are kept on ice. Solutions of 
pelargonidin and delphinidin were taken from stock and diluted to obtain a 
useable stock concentration if required. [3H]-ryanodine, SR, and pelargonidin or 
delphinidin are mixed to obtain desired final concentrations. Mixtures are placed 
in a 37oC water bath for the period of time needed for the experiment. At the end 
of the time period, the ryanodine binding reaction is then quenched by rapid 
filtration through Whatman GF/B glass fiber filter sheets on a Brandel cell 
harvester. Sample tubes are rinsed 2x using a standard rinse buffer similar to 
standard ryanodine buffer. Filtered samples are placed in scintillation vials with 
5ml scintillation fluid, placed on a shaker overnight, and then counted on a 
Beckman L-6500 scintillation counter. RyR non-specific binding is measured by 
addition of a 200X excess of non-labeled ryanodine to a control sample. Total 
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activity is measured by counting an unfiltered sample (2 nM  [3H]-ryanodine). 
Binding quantification is determined by the following equations: 
Equation 4.3  
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×
×
=
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5 Results 
5.1 Spectrometric Analysis of Ca2+ Efflux from SR Vesicles 
5.1.1 Pelargonidin Inhibits / Delphinidin Stimulates - Ca2+ Efflux from SR 
Vesicles 
This experiment was performed as noted in the methods section. Pg and Dp 
were added to the APIII buffer immediately (within 1 sec) prior to the addition of 
the Ca2+ loaded SR vesicles. At the concentrations tested (25µM and 50µM), the 
Pg and Dp stock solutions added 0.25% and 0.5% EtOH (vol) respectively to the 
APIII buffer. To minimize any effect that the EtOH may have on the RyR and 
Ca2+ efflux, 0.5% EtOH was also added to the control trials. Ruthenium Red 
(5µm) was utilized to ensure Ca2+ efflux was occurring through the RyR and not 
through other means such as membrane diffusion. Results show (Figure 5.1) that 
25µM and 50µM Pg both inhibit the release rate of Ca2+ from the RyR in a dose 
dependent manner and that 25µM and 50µM Dp both stimulate the release rate 
of Ca2+ from the RyR in a dose dependent manner with respect to the control. It 
is worth noting that 50µM Pg exhibits a [Ca2+]max that is less than half of the 
[Ca2+]max for all other traces. This may be due the existence of a high affinity Pg 
binding site that is exposed at higher levels of inhibition (higher Pg 
concentrations). Once the site is revealed, the abundant levels of Pg can bind 
strongly and effectively close the channel to Ca2+ flux. This is highly speculative 
 60
however and similar results were not duplicated in other concentration dependent 
experiments (see Figure 5.3). 
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Figure 5.1 Dp stimulates Ca
2+
 release and Pg inhibits Ca
2+
 release from the RyR1 of 
skeletal SR.  
 
Traces of Ca
2+
 efflux from Ca
2+
 loaded skeletal SR vesicles. Stock SR vesicles (~20 mg/ml 
protein) incubated with 1 mM CaCl2 overnight (~12-16 hours) on ice. Experiments 
performed in 200µM APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca
2+
 release is stimulated by 
dilution of SR into APIII buffer (~40:1). Final protein concentration = 0.3-0.5 mg/ml. Ca
2+
 
release is stimulated by both 25µM (▲) and 50µM (△) Dp and inhibited by both 25µM (▼) 
and 50µM (▽) Pg with respect to the control (■) (0.5% EtOH). 5µM (●) Ruthenium Red added 
to verify release is through RyR1. Both Pg and Dp were added to APIII buffer immediately 
prior to addition of SR. Error bars represent standard deviation for n=4 for control and n=3 
for all other data.  
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Figure 5.2 Initial Rate of Ca
2+
 Efflux from SR is Modulated by Pg and Dp.  
Initial rate of Ca
2+
 release is stimulated by both 25µM and 50µM Dp and inhibited by both 
25µM and 50µM Pg with respect to the control (0.5% EtOH). Data from figure 5.1 were fit to 
first order rise to max exponential functions and results used to calculate the initial rate. 
Experiments performed in 200µM APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca
2+
 release is 
stimulated by dilution of SR into APIII buffer (~40:1). Final protein concentration = 0.3-0.5 
mg/ml. Both Pg and Dp were added to APIII buffer immediately prior to addition of SR. 
Error bars represent standard deviation for n=4 for control and n=3 for all other data. 
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5.1.2 Pelargonidin Modulates the Initial Rate of Release in a Biphasic 
Manner 
The initial rate of Ca2+ efflux from the SR is stimulated by 1µM and 5µM 
concentrations of Pg. Concentrations from 40µM to 160µM showed increased 
inhibition of Ca2+ efflux. A traditional explanation for this type of biphasic behavior 
is the interaction with more than one class of binding sites on the RyR. At low 
micromolar concentration of Pg, binding to high affinity at binding sites results in 
channel activation, while at higher concentrations, binding to a lower affinity site 
results in inhibition of the channel. This may be the case here but Pg also can 
show prooxidant behavior at low concentrations and antioxidant behavior at 
higher concentrations (see chapter 1 and 3) and this characteristic may also 
contribute to the biphasic character shown here. The data in this section doesn’t 
support the decreased [Ca2+]max at higher Pg concentrations (Figure 5.1). The 
reason for this inconsistency is not known and warrants replicate trials to confirm 
results. The complex effect that Pg has on the RyR coupled with the lack of more 
detailed concentration dependence data would render further quantitative 
analysis as questionable and thus kinetic analysis will not be presented. 
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Figure 5.3 Pg modulates the initial rate of Ca
2+
 efflux from skeletal SR in a biphasic manner.  
Initial rate of Ca
2+
 release is stimulated by 1 µM and 5 µM Pg and inhibited by Pg 
concentrations greater than 10 µM with respect to the control (0.5% EtOH). Experiments 
performed in 200µM APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca
2+
 release is stimulated by 
dilution of SR into APIII buffer (~40:1). Stock SR vesicles (~20 mg/ml protein) incubated 
with 1 mM CaCl2 overnight (~12-16 hours) on ice. Pg was added to APIII buffer immediately 
prior to addition of SR. Final protein concentration = 0.3-0.5 mg/ml. Results shown are for 
one trial. 
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5.1.3 Delphinidin stimulates Ca2+ release from the RyR of the SR  
Delphinidin stimulates the initial rate of Ca2+ efflux from the RyR for all 
concentrations tested (Figure 5.3). EC50 = 9.3µM +/- 1.3µM (initial rate data 
(Table 5.4) fit to a four parameter logistic function (Figure 5.5)). The data is the 
result of only one trial at each concentration and therefore should be repeated to 
obtain statistical confidence. The data value at 80µM is approximately 30% less, 
and not in agreement with, the surrounding data point at 40µM and 160µM. The 
reason for this is unknown but I suspect that this is an artifact of an experimental 
error and warrants additional experimental confirmation. 
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Figure 5.4 Dp stimulates initial rate of Ca
2+
 release from skeletal SR.  
Initial rate of Ca
2+
 release is stimulated by Dp in a concentration dependent manner with 
respect to the control (~0.5% EtOH). Experiments performed in 200µM APIII, 100mM KCl, 
20mM HEPES, pH 7.4. Ca
2+
 release is stimulated by dilution of SR into APIII buffer (~40:1). 
Stock SR vesicles (~20 mg/ml protein) incubated with 1 mM CaCl2 overnight (~12-16 hours) 
on ice. Dp was added to APIII buffer immediately prior to addition of SR. Final protein 
concentration = 0.3-0.5 mg/ml. Results shown are for one trial. 
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Figure 5.5 Dp - Dose Response Curve.  
Dose-response data from figure 5.4 fit to a four parameter log function and the half 
maximal effective concentration (EC50) was obtained (Sigma Plot). EC50=9.3µM +/-1.3µM. 
Data point at 80µM (open circle) omitted from curve fit. Experiments performed in 200µM 
APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca
2+
 release is stimulated by dilution of SR into 
APIII buffer (~40:1). Stock SR vesicles (~20 mg/ml protein) incubated with 1 mM CaCl2 
overnight (~12-16 hours) on ice. Dp was added to APIII buffer immediately prior to addition 
of SR. Final protein concentration = 0.3-0.5 mg/ml. Results shown are for one trial.  
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5.1.4 Pelargonidin and Delphinidin; Different Forms, Different Effects 
Both pelargonidin and delphinidin undergo structural changes when exposed to 
weakly acidic to alkaline solutions (see chapters 1 and 3). The Ca2+ efflux assay 
has the benefit of being able to more tightly control the time in which Pg and Dp 
are exposed to the environmental conditions of the assay. In this experiment, 
stock Pg and Dp were diluted 1:1 in 20mM HEPES at pH7.4 and allowed to set 
for times periods of 1 hr, 2 hrs, and 4 hrs (all +/- 15 minutes). The samples were 
then used to determine their effect on Ca2+ efflux. Significant structural changes 
in Pg and Dp take place in this time period at pH7.4. Results show (Figure 5.6) 
that Dp loses its ability to stimulate the RyR by a factor of almost 2 after a 1hr 
exposure to pH7.4. An additional decrease in effectiveness is also seen after 
2hrs and 4hrs of dilution time with the final effect being only a slight stimulation of 
channel activity as compared to the control. Pg loses its inhibitory effect 
completely after 1 hour of exposure to pH7.4 and its effects on the RyR seem to 
change from inhibitory effect to a slight stimulating effect after 1hr of dilution.. 
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Figure 5.6 Time of exposure to pH7.4 alters the modulation effects that Dp and Pg have on 
the initial rate of Ca
2+
 release on skeletal SR.  
The inhibition effects of Pg (25µM) are lost after it is exposed to pH 7.4 for 1 hour and 
slight stimulatory effects are exhibited at longer exposures (2 and 4 hours). Dp (25µM) 
loses approximately half of its stimulatory effect after 1 hour and continues to lose its 
stimulatory action at longer exposures (2 and 4 hrs). Experiments performed in 200µM 
APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca
2+
 release is stimulated by dilution of SR into 
APIII buffer (~40:1). Stock SR vesicles (~20 mg/ml protein) incubated with 1 mM CaCl2 
overnight (~12-16 hours) on ice. Dp was added to APIII buffer immediately prior to addition 
of SR. Final protein concentration = 0.3-0.5 mg/ml. Error bars represent standard deviation 
for n=3 trial for the control, n=1 for 4hr Dp trial, and n=2 for all other trials. 
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5.2 Ryanodine Equilibrium Binding 
5.2.1 Pelargonidin and Delphinidin Modulate [3H]-Ryanodine Binding 
The equilibrium binding assay is carried out over for 3 hours to ensure chemical 
equilibrium of the binding of ryanodine to the RyR. Qualitatively, Figure 5.9 
shows that both Dp and Pg stimulate equilibrium binding with respect to the 
control but with Dp stimulating the channel more effectively than Pg. Quantitative 
analysis and determination of the EC50 would require an assay that includes a 
broader range of concentrations (greater than 25µM) and thus was not performed. 
Interestingly, in this assay, Pg exhibits a stimulatory effect. The reason for this is 
unknown but it can be hypothesized that the change is related to the structural 
and function changes that Pg undergoes during the 3 hour incubation at neutral 
pH conditions required for this assay. This stimulatory effect by Dp is consistent 
with the stimulatory effect seen in the Ca2+ efflux studies. 
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Figure 5.7 Pg and Dp stimulate ryanodine equilibrium binding. 
Both Dp (□) and Pg (◯) stimulate ryanodine equilibrium binding in a concentration 
dependent manner with respect to the control. Samples contain 4nM Ryanodine, 0.5 mg/ml 
SR vesicles, 50µM Ca
2+
 in pH 7.1 binding buffer. SR vesicles and ryanodine solutions kept 
on ice prior to dispensing into incubation tubes. Addition sequence: SR (1 mg/ml) in Ry 
buffer, 
3
[H]Ry in Ry buffer, and Pg or Dp. After addition of Pg/Dp samples are put in 37ºC 
bath, removed after 3hrs, and the reaction is quenched by rapid filtration.  
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5.3 Short Duration Ryanodine Binding 
Short duration Ry binding measures Ry binding over a time period of generally 
less than 20 minutes but other time periods can also be used. Figure 5.8 shows 
the results of this assay. Delphinidin clearly causes an increase in the initial rate 
of ryanodine binding with increasing concentration. Attempts made to fit the data 
to dose response curves did not converge. The lack of strong inhibition in this 
experiment by Pg can be partially attributed to the low level of binding by the 
control. In addition, changes in Pg’s structure and the resulting change in its 
effect on the RyR may also be of importance. In an attempt to enhance the 
background level of binding and better reveal the effects of Pg on ryanodine 
binding during initial exposure to pH7.1 buffers, assays were conducted with both 
5mM and 10mM caffeine, a known RyR stimulator, added to the experiment. 
Figure 5.9 shows that caffeine stimulated binding is strongly inhibited by Pg.
 73
[Pelargonidin]  (µM)
0 20 40 60
R
ya
n
o
d
in
e
 B
o
u
n
d
 (
5
 m
in
 in
cu
b
a
tio
n
) 
(p
m
o
l/m
g
)
0
1
2
3
4
5
 
Figure 5.8 Pelargonidin inhibits caffeine stimulated ryanodine binding 
Pelargonidin inhibits 5mM (◯) and 10mM (□) caffeine stimulated ryanodine binding in a 
concentration dependent manner with respect to the control. Samples contain 4nM 
3
[H]-
Ryanodine, 0.5 mg/ml SR vesicles, 50µM Ca
2+
 in pH 7.1 binding buffer. SR vesicles and 
ryanodine solutions kept on ice prior to dispensing into incubation tubes. Addition 
sequence: SR (1 mg/ml) in Ry buffer, 
3
[H]-Ry in Ry buffer, and Pg. After addition of Pg, 
samples are put in 37ºC bath for 5min and then removed and the reaction quenched by 
rapid filtration. 
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Figure 5.9 Comparison of 
3
[H]-ryanodine binding effects of Pg at short and long exposures 
to a pH 7.1 aqueous buffer.  
When Pg’s exposure to a pH 7.1 buffer is limited to 5 (▼) or 6 (▽) minutes, Pg inhibits 3[H]-
Ryanodine binding to the skeletal RyR. When the structural changes are allowed to 
proceed for 3 hours (▲), Pg stimulates 
3
[H]-ryanodine binding to the skeletal RyR. 
Samples contain 4nM 
3
[H]-ryanodine, 0.5 mg/ml SR vesicles, 50µM Ca
2+
 in pH 7.1 binding 
buffer. SR vesicles and ryanodine solutions kept on ice prior to dispensing into incubation 
tubes. Addition sequence: SR (1 mg/ml) in Ry buffer, 
3
[H]-Ry in Ry buffer, and Pg. After 
addition of Pg, samples are put in 37ºC bath for 5min and then removed and the reaction 
quenched by rapid filtration.   
 75
 
5.4 Spectrophotometric Characteristics of Pelargonidin and Delphinidin 
5.4.1 Absorbance Spectrum of Pg and Dp 
The absorbance spectrum exhibited by Pg and Dp is very dependent upon the 
pH of the solution as well as the time that Pg and Dp have been exposed to that 
pH. Figures 5.11 and 5.12 show the spectrums of Pg and Dp respectively at 
various pH’s. The spectrum was taken as quickly as possible (~3sec) after the 
dilution of 40 µM (final concentration) Pg or Dp from its EtOH stock solution into 
1mM Tris buffer at various pH’s. Results show the characteristic bathochromatic 
shifts of their spectrums that are expected at increasing pH (Cabrita, Fossen, and 
Øyvind M. Andersen 2000).  
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Figure 5.10 pH dependent absorbance spectrum of pelargonidin 
40uM Pg pipetted from 10mM stock in EtOH to 1mM TRIS (pH’d with HCl and/or KOH) and 
spectrum collected within 5 seconds. Solid line: pH=6.5, long dashes: pH=7.0, short 
dashes: pH=7.5, dotted trace: pH=8.0 
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Figure 5.11 pH dependent absorbance spectrum of delphinidin  
40uM Dp pipetted from 10mM stock in EtOH to 1mM TRIS (pH’d with HCl and/or KOH) and 
spectrum collected within 5 seconds. Solid line: pH=6.5, long dashes: pH=7.0, short 
dashes: pH=7.5, dotted trace: pH=8.0 
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5.4.2 pH Dependent Transformation Kinetics of Pg and Dp 
Upon dilution into a neutral pH solution, Pg and Dp rapidly deprotonate into their 
respective quinoidal base forms. This transformation occurs in a time frame 
faster than that required to add, mix, and collect the initial spectrum and thus 
cannot be followed using the technique described here. The subsequent slower 
transformation from the quinoidal base form to the carbinol pseudobase form is 
shown in Figure 5.13. The time required to add, mix, and collect the initial 
spectrum is on the order of a few seconds and therefore this measurement will 
only provide an estimate of the actual kinetics. However, this data is in 
agreement with the literature in that the transformation kinetics of these 
compounds increase with increasing acidity. In addition, the relative 
concentration of the quinoidal form with respect to the (colorless) carbinol form is 
dependent on pH. Unfortunately, the equilibrium constants for these compounds 
are not known and concentrations of the different forms cannot be determined. 
The kinetics of Pg and Dp are similar and when fitted to a first order decay 
equation, the t1/2 is on the order of 100 seconds at pH7.0. The kinetics 
significantly slow down at pH 7.5 and it is therefore not possible to estimate the 
t1/2 at this pH.  
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Figure 5.12 pH dependent transformation kinetics of Pg and Dp 
Kinetics of the decrease in absorbance of the quinoidal form of Pg and Dp over 300 
seconds. Traces for pH 6.5 (t1/2~50 sec), 7.0 (t1/2~50 sec), 7.5 (t1/2~not enough data) and 8.0 
(t1/2~not enough data) are shown. Black traces are Dp and Lt.Grey traces are Pg. Solid line: 
pH=6.5, long dashes: pH=7.0, short dashes: pH=7.5, dotted trace: pH=8.0. 
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6 Discussion 
The complex nature of pelargonidin and delphinidin with respect to their pH 
dependent molecular structures and properties makes it difficult to quantitatively 
assess the two compounds with regards to RyR modulation. However, calcium 
efflux experiments do allow for assessment of the effects of pelargonidin and 
delphinidin within seconds of exposure when concentrations of specific forms are 
known to dominate. Upon exposure to physiological pH solutions, pelargonidin 
and delphinidin rapidly (~1 second) deprotonate to their corresponding quinoidal 
base and quinoidal base anion forms whereas the subsequent transformation to 
the carbinol pseudobase is on the order of minutes at pH 7 and significantly 
longer in more alkaline solutions. The Ca2+ efflux assays utilized in this thesis can 
probe the modulatory effect that a compound has on the channel in time periods 
as short as several seconds and therefore can effectively assay pelargonidin and 
delphinidin in their quinoidal forms. Additionally, the transformation of 
pelargonidin and delphinidin to the chalcone form is likely on the order of twelve 
to twenty four hours (based on similar compounds found in literature) and 
therefore there is a time period after the transformation into the carbinol 
pseudobase that the Ca2+ efflux assay can probe the effects of that form as well.  
Delphinidin is predicted to be in a quinoidal base anion form almost immediately 
after exposure to a pH 7.4 solution. Hydroxyl groups at positions 4’ and 5 are the 
predicted deprotonation sites. Calcium efflux results show that delphinidin is a 
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good RyR1 stimulator with an EC50 of 9.3µM. However this result is obtained 
within the first fraction of a minute after Dp is exposed to the pH 7.4 of the Ca2+ 
efflux buffer. When Dp is allowed to transform into the carbinol pseudobase form, 
a majority of its stimulatory effects are essentially lost. This implies that the 
quinoidal base form is primarily responsible for Dp’s stimulatory effects on the 
RyR. This also implies that the carbinol pseudobase form doesn’t have a strong 
modulatory effect. Although there is still a small stimulatory effect seen even after 
the carbinol is formed, this may be due to the fact that there is still an equilibrium 
concentration (not known) of quinoidal base in solution or that stimulatory 
autoxidation products of Dp are present in the solution (both superoxide and 
hydrogen peroxide have been shown to stimulate the RyR1 (T. G Favero, A. C 
Zable, and J. J Abramson 1995; Kawakami and Okabe 1998)). [3H]-ryanodine 
binding experiments at both short [3H]-ryanodine incubation times (~ 6 minutes 
(data not shown)) and long incubation times (~ 3 hours) also show stimulatory 
effects. Again, the stimulatory effects for longer time periods are suspect in part 
due to the autoxidation capabilities of Dp. 
With pelargonidin, the modulating mechanism is more complex. Pelargonidin is 
also predicted to be in a quinoidal base anion form immediately after exposure to 
a pH 7.4 solution. Hydroxyl groups at positions 5 and 4’ are the predicted 
deprotonation sites but the 5 and 3 are close in energy and probably co-exists in 
significant concentrations. Calcium efflux results imply that the quinoidal form of 
pelargonidin is a RyR1 inhibitor. In contrast, the carbinol pseudobase does not 
 82
seem to be effective at inhibiting the RyR. There is even a slight hint of some 
channel stimulatory effects. [3H]-ryanodine binding experiments performed with 
short [3H]-ryanodine incubation times (~ 5 minutes) also show activation of 
receptor binding. As is the case with delphinidin, the structural form 3 hours after 
exposure to neutral pH conditions is also the carbinol pseudobase although, for 
pelargonidin,  the predicted (lowest) pKa  of that form is 8.32 (3-OH) and 
therefore it probably exists with a neutral charge. Longer [3H]-ryanodine 
incubation times (~ 3 hours) exhibited significant channel stimulatory effects on 
the RyR. Unlike Dp, Pg is not known to autoxidize and therefore the generation 
of oxidation products doesn’t seem to be a probable explanation for the 
stimulatory action.  
 For the quinoidal base forms, both compounds are predicted to be planar and 
both compounds are charged with the deprotonation sites on the 5 and 4’ 
oxygens. However, the relative order of the acidities of the hydrogens of those 
groups are reversed. Dp loses its first hydrogen at O4’ (experimental pKa1~5.30) 
and its second hydrogen at O5 (predicted pKa2~6.30) whereas pelargonidin loses 
its first hydrogen at O5 (experimental pKa1~5.79) and its second hydrogen at O4’ 
(predicted pKa2~7.05). The second predicted deprotonation of pelargonidin is 
also close to the pH of the assays performed in this thesis (pH7.1 for ryanodine 
binding and pH7.4 for Ca2+ efflux) which means that pelargonidin will exist as 
more of a mixture of both the neutral quinoidal base and the anionic quinoidal 
base forms. This may impart more of a hydrogen donor characteristic to 
 83
pelargonidin relative to delphinidin. The relative order of the deprotonation sites 
may also impart differing molecular polarization characteristics to Pg. How this 
may affect the RyR is unknown due to the lack of knowledge regarding the Pg 
(and Dp) binding site(s). Structural information regarding the carbinol 
pseudobase forms of these compounds was not found in literature however the 
predicted pKa2 of the carbinol pseudobase forms of pelargonidin and delphinidin 
are 8.35 (at the 3-OH) and 7.25 (at the 4’ OH) respectively. Thus, when the 
carbinol pseudobase structures are formed (in neutral pH conditions), 
pelargonidin carries mostly a neutral charge whereas Dp is in a mixture of neutral 
and anionic forms (Borkowski et al. 2005).  
 
In conclusion, the distinct and powerful effects that the anthocyanidin compounds 
studied in this thesis potentially have on skeletal ryanodine receptor mediated 
Ca2+ homeostasis is further proof of the necessity to fully understand the 
complete effects of nutraceuticals before dietary intake recommendations can be 
made.  
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